COMMISSION IMPLEMENTING REGULATION (EU) No 1014/2013
of 22 October 2013
amending Regulations (EC) No 2380/2001, (EC) No 1289/2004, (EC) No 1455/2004, (EC) No 1800/2004, (EC) No 600/2005, (EU) No 874/2010, Implementing Regulations (EU) No 388/2011, (EU) No 532/2011 and (EU) No 900/2011 as regards the name of the holder of the authorisation of certain additives in animal feed
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in animal nutrition (1) and in particular Article 13(3) thereof,
Whereas:
(1)
Pfizer Ltd has submitted an application in accordance with Article 13(3) of Regulation (EC) No 1831/2003 proposing to change the name of the holder of the authorisations as regards Commission Regulations (EC) No 2380/2001 (2), (EC) No 1289/2004 (3), (EC) No 1455/2004 (4), (EC) No 1800/2004 (5), (EC) No 600/2005 (6), (EU) No 874/2010 (7), Commission Implementing Regulations (EU) No 388/2011 (8), (EU) No 532/2011 (9) and (EU) No 900/2011 (10).
(2)
The applicant claims that, as a result of Pfizer Ltd’s decision to make its Animal Health Division a stand-alone company under the name of Zoetis Belgium SA and transfer all the marketing authorisations for coccidiostats from Pfizer Ltd to Zoetis Belgium SA, the latter owns the marketing rights for the additives decoquinate, lasalocid A sodium, maduramicin ammonium alpha, robenidine hydrochloride and salinomycin.
(3)
The proposed change of the terms of the authorisations is purely administrative in nature and does not entail a new assessment of the additives concerned. The European Food Safety Authority was informed of the application.
(4)
To allow the applicant to exploit its marketing rights under the name of Zoetis Belgium SA it is necessary to change the terms of the respective authorisations.
(5)
Regulations (EC) No 2380/2001, (EC) No 1289/2004, (EC) No 1455/2004, (EC) No 1800/2004, (EC) No 600/2005, (EU) No 874/2010, and Implementing Regulations (EU) No 388/2011, (EU) No 532/2011 and (EU) No 900/2011 should therefore be amended accordingly.
(6)
Since the modifications to the terms of the authorisations are not related to safety reasons, it is appropriate to provide for a transitional period during which existing stocks may be used up.
(7)
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,
HAS ADOPTED THIS REGULATION:
Article 1
Amendment to Regulation (EC) No 2380/2001
In the second column of the Annex, the words ‘Pfizer Ltd’ are replaced by ‘Zoetis Belgium SA’.
Article 2
Amendment to Regulation (EC) No 1289/2004
In the second column of the Annex, the words ‘Pfizer Ltd’ are replaced by ‘Zoetis Belgium SA’.
Article 3
Amendment to Regulation (EC) No 1455/2004
In the second column of the Annex, the words ‘Pfizer Ltd’ are replaced by ‘Zoetis Belgium SA’.
Article 4
Amendment to Regulation (EC) No 1800/2004
In the second column of the Annex, the words ‘Pfizer Ltd’ are replaced by ‘Zoetis Belgium SA’.
Article 5
Amendment to Regulation (EC) No 600/2005
In the second column of Annex I, the words ‘Pfizer Ltd’ are replaced by ‘Zoetis Belgium SA’.
Article 6
Amendment to Regulation (EU) No 874/2010
Regulation (EU) No 874/2010 is amended as follows:
(a)
in the title, the words ‘Alpharma (Belgium) BVBA’ are replaced by ‘Zoetis Belgium SA’;
(b)
in the second column of the Annex, the words ‘Pfizer Ltd’ are replaced by ‘Zoetis Belgium SA’.
Article 7
Amendment to Implementing Regulation (EU) No 388/2011
Implementing Regulation (EU) No 388/2011 is amended as follows:
(a)
in the title, the words ‘Alpharma (Belgium) BVBA’ are replaced by ‘Zoetis Belgium SA’;
(b)
in the second column of the Annex, the words ‘Pfizer Ltd’ are replaced by ‘Zoetis Belgium SA’.
Article 8
Amendment to Implementing Regulation (EU) No 532/2011
Implementing Regulation (EU) No 532/2011 is amended as follows:
(a)
in the title, the words ‘Alpharma Belgium BVBA’ are replaced by ‘Zoetis Belgium SA’;
(b)
in the second column of Annex I, the words ‘Pfizer Ltd’ are replaced by ‘Zoetis Belgium SA’;
Article 9
Amendment to Implementing Regulation (EU) No 900/2011
Implementing Regulation (EU) No 900/2011 is amended as follows:
(a)
in the title, the words ‘Alpharma (Belgium) BVBA’ are replaced by ‘Zoetis Belgium SA’;
(b)
in the second column of the Annex to Regulation (EU) No 900/2011, the words ‘Pfizer Ltd’ are replaced by ‘Zoetis Belgium SA’.
Article 10
Transitional measures
The existing stocks which have been produced and labelled before 12 November 2013 in accordance with the rules applicable before 12 November 2013 may continue to be placed on the market and used until they are exhausted.
Article 11
Entry into force
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
This Regulation is binding in its entirety and directly applicable in all Member States.
Done at Brussels, 22 October 2013.